252 results
Page 5 of 13
8-K
86copg
22 Jun 20
Material Modifications to Rights of Security Holders
4:18pm
8-K
EX-3.1
3tcflf8czo4ymq0cnnt3
22 Jun 20
Material Modifications to Rights of Security Holders
4:18pm
8-K
EX-99.1
4y163
16 Jun 20
Entry into a Material Definitive Agreement
4:48pm
8-K
0bt61uhcw jap
16 Jun 20
Entry into a Material Definitive Agreement
4:48pm
8-K
EX-99.1
j9gdyp4 yxozd9wwpu
18 May 20
Adamis Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update
4:57pm
8-K
y9v2i10qi ceqfp7ixd
13 May 20
Adamis Pharmaceuticals Provides Update on SYMJEPI Products and Announces Distribution and Commercialization Agreement for SYMJEPI and ZIMHI Products
5:20pm
8-K
EX-99.1
zq3iz7
13 May 20
Adamis Pharmaceuticals Provides Update on SYMJEPI Products and Announces Distribution and Commercialization Agreement for SYMJEPI and ZIMHI Products
5:20pm
8-K
EX-99.1
bb3rti16wrh
30 Mar 20
Adamis Pharmaceuticals Announces 2019 Financial Results and Business Update
4:50pm
424B5
21pjg6bn7vc4k
24 Feb 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-10.1
rkot0jd r59
21 Feb 20
Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
5:24pm
8-K
EX-99.2
yifvsral
21 Feb 20
Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
5:24pm
8-K
EX-99.1
f2gpwqg5c38672xijf
26 Dec 19
Adamis Pharmaceuticals Provides an Update on ZIMHI
4:59pm
8-K
EX-99.1
389qow
25 Nov 19
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
9:16am
8-K
EX-99.1
zasaw41
12 Nov 19
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update
4:41pm
8-K
EX-99.1
9zihyqxj799c8
8 Aug 19
Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
4:55pm